<html>
<head>PUBMED IDs for NKAIN2</head>
<body bgcolor='#C5F0F2'><h1>NKAIN2</h1><a href='https://pubmed.ncbi.nlm.nih.gov/21445666/'>Family-based association analysis of alcohol dependence in the COGA sample and replication in the Australian twin-family study.</a> June 2  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/23903073/'>Genome-wide association study of the five-factor model of personality in young Korean women.</a> April 22  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23903072/'>CEBPE promoter SNPs, caught red handed? A commentary on identification of functional nucleotide and haplotype variants in the promoter of the CEBPE gene.</a> April 3  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24205241/'>High-resolution array CGH profiling identifies Na/K transporting ATPase interacting 2 (NKAIN2) as a predisposing candidate gene in neuroblastoma.</a> February 24  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24205231/'>Plasma metabolomics reveal alterations of sphingo- and glycerophospholipid levels in non-diabetic carriers of the transcription factor 7-like 2 polymorphism rs7903146.</a> February 24  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/25562418/'>High-resolution 400K oligonucleotide array comparative genomic hybridization analysis of neurofibromatosis type 1-associated cutaneous neurofibromas.</a> April 17  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/25562415/'>Development and validation of the JAX Cancer Treatment Profileâ„¢ for detection of clinically actionable mutations in solid tumors.</a> May 23  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/25562367/'>microRNA-328 is a favorable prognostic marker in human glioma via suppressing invasive and proliferative phenotypes of malignant cells.</a> September 23  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/25637059/'>Pure interstitial dup(6)(q22.31q22.31) - a case report.</a> February 9  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26770299/'>The structure and function of NKAIN2-a candidate tumor suppressor.</a> January 16  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27588475/'>NKAIN2 functions as a novel tumor suppressor in prostate cancer.</a> September 3  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/28381166/'>Downregulation of microRNA-181d had suppressive effect on pancreatic cancer development through inverse regulation of KNAIN2.</a> April 19  2017<br></body></html>
